Sangamo BioSciences | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Alaunos Therapeutics USD 2.06M 661K 2024-12
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amgen USD 6.21B 330M 2025-03
Bayer EUR 32.58B 537M 2025-03
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Cipla INR 311.93B 27.38B 2025-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 54.91M 5.57M 2024-12
CSL USD 20.55B 3.18B 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Grifols EUR 5.88B 533.83M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
J&J USD 78.11B 6.62B 2025-03
Merck USD 48.34B 2.02B 2025-03
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 74.07B 3.78B 2025-03
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
Tectonic Therapeutic USD 140.78M 9.58M 2024-12
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Sangamo BioSciences Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.